Price (delayed)
$1.24
Market cap
$39.57M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.26
Enterprise value
$28.29M
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using
There are no recent dividends present for CODX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.